Ildong Pharmaceutical Co., Ltd. (KRX: 249420)

Ildong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	48,316	53,258	52,146	135,586	85,564	89,959
Short-Term Investments	22,596	28,021	16,600	19,095	600	600
Trading Asset Securities	-	-	10,000	-	-	-
Cash & Short-Term Investments	70,913	81,279	78,746	154,681	86,164	90,559
Cash Growth	30.44%	3.22%	-49.09%	79.52%	-4.85%	16.65%
Accounts Receivable	56,807	56,245	53,916	51,818	49,517	63,643
Other Receivables	3,160	2,735	4,158	3,026	1,241	2,832
Receivables	68,636	62,650	58,074	54,844	50,758	66,979
Inventory	93,671	84,623	98,249	82,587	89,227	69,744
Prepaid Expenses	2,021	1,623	1,270	1,363	1,408	1,627
Other Current Assets	6,290	5,506	45,697	7,008	5,686	4,457
Total Current Assets	241,529	235,681	282,035	300,485	233,243	233,367
Property, Plant & Equipment	254,817	256,380	255,317	247,790	256,419	259,521
Long-Term Investments	17,141	18,996	21,395	22,432	21,675	11,584
Goodwill	5,527	5,527	5,527	5,527	-	-
Other Intangible Assets	26,009	30,079	31,401	38,926	38,283	39,653
Long-Term Accounts Receivable	345.62	442.14	542.83	-	-	-
Long-Term Deferred Tax Assets	48,192	53,888	43,822	66,016	24,935	32,263
Long-Term Deferred Charges	6,371	6,505	10,193	22,174	24,788	29,955
Other Long-Term Assets	2,696	1,689	3,630	3,808	4,213	4,463
Total Assets	604,712	611,261	655,810	708,970	605,277	612,723
Accounts Payable	55,108	50,250	46,099	38,334	35,988	39,764
Accrued Expenses	35,111	33,277	33,734	34,930	20,804	27,002
Short-Term Debt	161,040	164,672	140,743	88,400	65,400	74,400
Current Portion of Long-Term Debt	3,000	13,000	1,000	42,000	23,000	33,000
Current Portion of Leases	4,194	3,575	6,618	4,035	3,956	3,336
Current Income Taxes Payable	722.51	68.3	268.05	7.55	129.16	1,389
Current Unearned Revenue	-	-	-	600	-	-
Other Current Liabilities	54,397	44,273	82,182	149,456	35,733	32,951
Total Current Liabilities	313,573	309,115	310,644	357,763	185,010	211,843
Long-Term Debt	30,000	14,825	16,000	60,404	42,000	23,000
Long-Term Leases	18,760	16,654	43,387	31,316	32,500	32,185
Long-Term Deferred Tax Liabilities	1.43	1.43	6.06	-	-	-
Other Long-Term Liabilities	10,636	29,099	9,688	10,375	10,328	10,110
Total Liabilities	433,162	431,880	451,940	542,008	350,730	359,831
Common Stock	28,063	28,063	26,803	23,803	23,803	22,670
Additional Paid-In Capital	173,359	173,359	377,287	210,262	209,614	238,947
Retained Earnings	-62,509	-58,540	-211,102	-81,951	14,856	-4,872
Treasury Stock	-2,307	-2,307	-365.05	-365.05	-365.05	-321.71
Comprensive Income & Other	27,192	28,968	-1,379	1,159	6,640	-3,532
Total Common Equity	163,798	169,543	191,244	152,909	254,547	252,892
Minority Interest	2,637	4,723	6,981	7,676	-	-
Shareholders' Equity	171,550	179,381	203,870	166,962	254,547	252,892
Total Liabilities & Equity	604,712	611,261	655,810	708,970	605,277	612,723
Total Debt	216,994	212,726	207,748	226,155	166,856	165,922
Net Cash (Debt)	-146,082	-131,447	-129,002	-71,474	-80,692	-75,362
Net Cash Per Share	-5292.10	-4862.98	-4896.88	-3004.97	-3392.40	-3167.75
Filing Date Shares Outstanding	27.93	27.93	26.79	23.79	23.79	22.66
Total Common Shares Outstanding	27.93	27.93	26.79	23.79	23.79	23.79
Working Capital	-72,043	-73,434	-28,609	-57,279	48,233	21,525
Book Value Per Share	5864.08	6069.76	7139.87	6428.69	10701.87	10630.38
Tangible Book Value	132,262	133,936	154,315	108,456	216,264	213,238
Tangible Book Value Per Share	4735.07	4795.03	5761.20	4559.77	9092.34	8963.54
Land	72,561	72,561	35,125	35,125	35,125	35,125
Buildings	90,627	141,614	140,941	140,732	138,731	137,300
Machinery	64,493	211,982	206,257	195,601	185,845	174,805
Construction In Progress	7,132	3,694	1,963	3,683	5,988	6,204

Source: S&P Capital IQ. Standard template. Financial Sources.